Role of gain of 12p in germ cell tumour development
- PMID: 12752258
- DOI: 10.1034/j.1600-0463.2003.11101201.x
Role of gain of 12p in germ cell tumour development
Abstract
Within the human testis, three entities of germ cell tumours are distinguished: the teratomas and yolk sac tumors of newborn and infants, the seminomas and nonseminomas of adolescents and young adults, referred to as testicular germ cell tumours (TGCT), and the spermatocytic seminomas. Characteristic chromosomal anomalies have been reported for each group, supporting their distinct pathogenesis. TGCT are the most common cancer in young adult men. The initiating pathogenetic event of these tumours occurs during embryonal development, affecting a primordial germ cell or gonocyte. Despite this intra-uterine initiation, the tumour will only be clinically manifest after puberty, with carcinoma in situ (IS) as the precursor. All invasive TGCT, both seminomas and nonseminomas, as well as CIS cells are aneuploid. The only consistent (structural) chromosomal abnormalities in invasive TGCT are gains of the short arm of chromosome 12, mostly due to isochromosome (i(12p)) formation. This suggests that an increase in copy number of a gene(s) on 12p is associated with the development of a clinically manifest TGCT. Despite the numerous (positional) candidate gene approaches that have been undertaken thus far, identification of a causative gene(s) has been hampered by the fact that most 12p gains involve rather large genomic intervals, containing unmanageable numbers of candidate genes. Several years ago, we initiated a search for 12p candidate genes using TGCT with a restricted 12p-amplification, cytogenetically identified as 12p11.2-p12.1. This approach is mainly based on identification of candidate genes mapped within the shortest region of overlap of amplification (SROA). In this review, data will be presented, which support the model that gain of 12p-sequences is associated with suppression of apoptosis and Sertoli cell-independence of CIS cells. So far, DAD-R is one of the most likely candidate genes involved in this process, possibly via N-glycosylation. Preliminary results on high through-put DNA- and cDNA array analyses of 12p-sequences will be presented.
Similar articles
-
Pathogenesis of testicular germ cell tumours.Rev Reprod. 1999 May;4(2):90-100. doi: 10.1530/ror.0.0040090. Rev Reprod. 1999. PMID: 10357096 Review.
-
Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation.Cancer Res. 2002 Mar 15;62(6):1822-31. Cancer Res. 2002. PMID: 11912161
-
Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1.Oncogene. 2003 Mar 27;22(12):1880-91. doi: 10.1038/sj.onc.1206302. Oncogene. 2003. PMID: 12660824
-
Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults.Oncogene. 1998 May;16(20):2617-27. doi: 10.1038/sj.onc.1201787. Oncogene. 1998. PMID: 9632138
-
The testicular germ cell tumour genome.APMIS. 2003 Jan;111(1):136-50; discussion 50-1. doi: 10.1034/j.1600-0463.2003.11101181.x. APMIS. 2003. PMID: 12752254 Review.
Cited by
-
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.Indian J Urol. 2010 Jan-Mar;26(1):64-71. doi: 10.4103/0970-1591.60454. Indian J Urol. 2010. PMID: 20535289 Free PMC article.
-
Urologic conditions associated with malignancy.Urol Oncol. 2020 Jan;38(1):23-30. doi: 10.1016/j.urolonc.2018.12.018. Epub 2019 Jan 2. Urol Oncol. 2020. PMID: 30611645 Free PMC article. Review.
-
[The role of tumour markers in diagnosis and management of testicular germ cell tumours].Urologe A. 2011 Mar;50(3):313-21. doi: 10.1007/s00120-010-2414-5. Urologe A. 2011. PMID: 21327901 German.
-
New insights into the pathology and molecular biology of human germ cell tumors.World J Urol. 2004 Apr;22(1):15-24. doi: 10.1007/s00345-004-0399-7. Epub 2004 Mar 20. World J Urol. 2004. PMID: 15042404 Review.
-
ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.Biomedicines. 2023 Jul 4;11(7):1894. doi: 10.3390/biomedicines11071894. Biomedicines. 2023. PMID: 37509533 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical